Core Viewpoint - Shengyuan Environmental Protection (300867) is actively preparing for the launch of new products and will schedule production and market release based on project progress and market demand [1] Group 1 - The company is currently engaged in the pre-launch preparations for related new products [1] - Future production and market release will be arranged appropriately according to project progress and market demand [1]

Core Viewpoint - Shengyuan Environmental Protection (300867) forecasts a net profit attributable to shareholders of the listed company for 2025 to be between 240 million and 290 million yuan, representing a year-on-year growth of 31.79% to 59.24% [1] Summary by Category - **Company Performance** - The company expects a significant increase in net profit for 2025, with projections indicating a range of 240 million to 290 million yuan [1] - This anticipated growth reflects a robust year-on-year increase of 31.79% to 59.24% compared to the previous year [1]

Group 1 - The core viewpoint of the article is that Shengyuan Environmental Protection (300867) has announced its 2025 annual performance forecast, expecting a net profit of between 240 million to 290 million yuan, representing a year-on-year growth of 31.79% to 59.24% [1] - The net profit excluding non-recurring gains and losses is projected to be between 245 million to 295 million yuan, indicating a year-on-year increase of 47.88% to 78.06% [1]

Group 1 - ShenNan Electric A expects a net profit increase of 584.66%-721.59% year-on-year for 2025 [1] - Te Yi Pharmaceutical anticipates a net profit increase of 241.55%-339.13% year-on-year for 2025 [1] - RunTu Co. forecasts a net profit increase of 181.05%-227.89% year-on-year for 2025 [1] - QingSong Co. projects a net profit increase of 137.73%-201.74% year-on-year for 2025 [1] - RuiSheng Intelligent expects a net profit increase of 112.00%-139.99% year-on-year for 2025 [1] - JianKai Technology anticipates a net profit increase of 101.09%-121.20% year-on-year for 2025 [1] - XingQi Eye Medicine forecasts a net profit increase of 95.82%-121.56% year-on-year for 2025 [1] - RuiChuang MicroNano expects a net profit increase of approximately 93% year-on-year for 2025 [1] - TianHe Co. projects a net profit increase of 84.35%-169.78% year-on-year for 2025 [1] - ZhongYuan Co. anticipates a net profit increase of 80%-105% year-on-year for 2025 [1] - YiDao Information expects a net profit increase of 76.04%-128.85% year-on-year for 2025 [1] - ShengDa Bio forecasts a net profit increase of 69.93%-120.90% year-on-year for 2025 [1] - HuaRui Precision anticipates a net profit increase of 68.29%-86.99% year-on-year for 2025 [1] - FangZheng Technology expects a net profit increase of 67.06%-98.14% year-on-year for 2025 [1] - JinLing Hotel projects a net profit increase of 65.37%-90.93% year-on-year for 2025 [1] - QiangYi Co. anticipates a net profit increase of 57.87%-71.17% year-on-year for 2025 [1] - LangBo Technology expects a net profit increase of 57.58%-66.53% year-on-year for 2025 [1] - HuaFeng Measurement and Control forecasts a net profit increase of 46%-78% year-on-year for 2025 [1] - Zhaoyi Innovation anticipates a net profit increase of approximately 46% year-on-year for 2025 [1] - JieChang Drive expects a net profit increase of 40%-55% year-on-year for 2025 [1] - ShengYuan Environmental Protection projects a net profit increase of 31.79%-59.24% year-on-year for 2025 [1] - GuangHa Communication anticipates a net profit increase of 21.83%-31.31% year-on-year for 2025 [1] - MaiHe Co. expects a net profit increase of 19.58%-54.76% year-on-year for 2025 [1] Group 2 - YiLing Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan for 2025, turning profitable year-on-year [1] - LiYade anticipates a net profit of 300 million to 380 million yuan for 2025, turning profitable year-on-year [1] - SiRuiPu expects a net profit of 165 million to 184 million yuan for 2025, turning profitable year-on-year [1] - DaMing City anticipates a net profit of 140 million to 165 million yuan for 2025, turning profitable year-on-year [1] - DaHeng Technology expects a net profit of 106 million yuan for 2025, turning profitable year-on-year [1] - GuangHua Technology projects a net profit of 85 million to 120 million yuan for 2025, turning profitable year-on-year [1] - BoTeng Co. expects a net profit of 80 million to 105 million yuan for 2025, turning profitable year-on-year [2] - ZhongBing HongJian anticipates a net profit of 34 million to 46 million yuan for 2025, turning profitable year-on-year [2]

Major Announcements - Zhaoyi Innovation plans to use 500 million CNY of A-share fundraising to increase capital in its wholly-owned subsidiaries for the implementation of the DRAM project [1] - Haiguang Information's mid-2025 profit distribution plan includes a cash dividend of 0.09 CNY per share, totaling 209 million CNY [2] - *ST Biology has terminated the major asset restructuring plan to acquire 51% of Hunan Huize Biomedical Technology Co., Ltd. [3] - Fosun Pharma intends to spin off its subsidiary Fosun Antigen for independent listing on the Hong Kong Stock Exchange [4] - Jingchen Co. has set the inquiry transfer price at 82.85 CNY per share for the transfer of 13.1 million shares [5] Performance Forecasts - Zhaoyi Innovation expects a net profit of approximately 1.61 billion CNY for 2025, a year-on-year increase of about 46% [9] - Longying Precision anticipates a net profit decrease of 17.70% to 29.36% for 2025, estimating between 545 million CNY and 635 million CNY [9] - Ruichuang Micro-Nano forecasts a net profit of around 1.1 billion CNY for 2025, representing a 93% increase [10] - Nanjing Bank projects a net profit of 21.81 billion CNY for 2025, an 8.08% increase year-on-year [11] - Zhongyuan Co. expects a net profit increase of 80% to 105% for 2025, estimating between 139 million CNY and 158 million CNY [12] - Qiangyi Co. anticipates a net profit increase of 57.87% to 71.17% for 2025, estimating between 368 million CNY and 399 million CNY [13] - Liard expects a net profit of 300 million CNY to 380 million CNY for 2025, turning from a loss of 889 million CNY in the previous year [14] - Daheng Technology forecasts a net profit of approximately 106 million CNY for 2025, also turning from a loss [16] - Dongfeng Co. anticipates a net loss of 390 million CNY to 480 million CNY for 2025 [17] - Qing Song Co. expects a net profit increase of 137.73% to 201.74% for 2025, estimating between 130 million CNY and 165 million CNY [18] - SIRUI Co. forecasts a net profit of 165 million CNY to 184 million CNY for 2025, turning from a loss [19] - Shengmei Shanghai expects a revenue increase of 18.91% to 22.47% for 2025, estimating between 6.68 billion CNY and 6.88 billion CNY [20] - Yijun Co. anticipates a net loss of 11 million CNY to 14 million CNY for 2025 [21] - Saint Yuan Environmental Protection expects a net profit increase of 31.79% to 59.24% for 2025, estimating between 240 million CNY and 290 million CNY [22] - Lijun Co. forecasts a net profit decrease of 45.05% to 60.03% for 2025, estimating between 4.8 million CNY and 6.6 million CNY [23] - Xingqi Eye Medicine expects a net profit increase of 95.82% to 121.56% for 2025, estimating between 662 million CNY and 749 million CNY [25] - Beidou Star expects a net loss of 230 million CNY to 290 million CNY for 2025, reducing losses compared to the previous year [26] - Yiling Pharmaceutical anticipates a net profit of 1.2 billion CNY to 1.3 billion CNY for 2025, turning from a loss of 725 million CNY [27] - Zhijiang Bio forecasts a net loss of 32 million CNY to 47 million CNY for 2025, reducing losses compared to the previous year [28] - Yema Battery expects a net profit decrease of 58% to 70% for 2025, estimating between 45.83 million CNY and 64.17 million CNY [29] - Yunmei Energy anticipates a net loss of 410 million CNY to 470 million CNY for 2025 [30] - Yingfang Micro expects a net loss of 69 million CNY to 97 million CNY for 2025 [31] - Guanghua Technology forecasts a net profit of 85 million CNY to 120 million CNY for 2025, turning from a loss [33] Share Buybacks - Hengyi Petrochemical plans to repurchase shares worth 500 million CNY to 1 billion CNY [34] - Yunyi Electric plans to repurchase shares worth 100 million CNY to 150 million CNY [34] - Xidun Pharmaceutical plans to repurchase shares worth 25 million CNY to 50 million CNY [35]

圣元环保（300867）(300867.SZ)披露2025年年度业绩预告，公司预计归属于上市公司股东的净利润2.4 亿元至2.9亿元，同比增长31.79%至59.24%;扣除非经常性损益后的净利润2.45亿元至2.95亿元，同比增 长47.88%至78.06%。 ...

Group 1 - The company Shengyuan Environmental Protection (300867.SZ) has disclosed its annual performance forecast for 2025, expecting a net profit attributable to shareholders of between 240 million to 290 million yuan, representing a year-on-year growth of 31.79% to 59.24% [1] - The net profit after deducting non-recurring gains and losses is anticipated to be between 245 million to 295 million yuan, with a year-on-year increase of 47.88% to 78.06% [1]

Core Viewpoint - Shengyuan Environmental Protection (300867) expects a net profit attributable to shareholders of 240 million to 290 million yuan for 2025, representing a year-on-year growth of 31.79% to 59.24% [1] Group 1: Performance Factors - The company's revenue is expected to remain stable during the reporting period [1] - The decrease in operating costs is attributed to refined management and technological upgrades [1] - Improved collection of accounts receivable has led to a reduction in credit impairment losses [1] - An increase in VAT refunds and a decrease in interest expenses have positively impacted the financial performance [1]

圣元环保股份有限公司 2025 年年度业绩预告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、本期业绩预告情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日 2、业绩预告情况：自愿性业绩预告 证券代码：300867 证券简称：圣元环保 公告编号：2026-002 二、与会计师事务所沟通情况 本次业绩预告相关数据未经会计师事务所审计。公司已就业绩预 告有关事项与年报审计会计师事务所进行了预沟通，公司与会计师事 务所在本报告期的业绩预告方面不存在重大分歧。 三、业绩变动原因说明 报告期内，公司业绩变动主要系以下因素综合影响：收入基本持 平，公司通过精细化管理及技术改造，实现营业成本下降；应收账款 回收情况良好，信用减值损失减少；增值税退税增加，利息支出下降。 1 四、其他相关说明 公司全资子公司厦门金陵基建筑工程有限公司 2025 年度认购私 募理财产品本金 6000 万元，最终赎回款 1,107.78 万元，目前已追回 损失款项 960 万元。针对前述全资子公司委托理财亏损事项，公司控 股股东、实际控制人已承诺于公司 ...

Core Viewpoint - The company is actively progressing with the transfer of its wastewater business assets and is in the process of obtaining necessary government approvals, with further details to be disclosed in official announcements [2]. Group 1: Asset Transfer and Financial Impact - The company is working on the transfer of its wastewater business assets, with the current status pending government approval [2]. - The potential financial benefits from the asset transfer will be clarified in future company announcements [2]. Group 2: Food Project Development - The food and pharmaceutical health industry project is currently in the preliminary design phase, with associated groundwork activities being conducted simultaneously [2]. - The timeline for the commencement of construction will be disclosed based on the progress of the project [2]. Group 3: New Subsidiary and Strategic Focus - The company has established a wholly-owned subsidiary, Yuanqi Zhenxuan Network Technology Co., Ltd., in January, focusing on the sales of taurine-related derivative products [2]. - This new subsidiary represents a significant strategic move for the company to deepen its involvement in the health industry sector [2].